Arecor Therapeutics PLC (AREC) — Financial Flexibility Index
Arecor Therapeutics PLC (AREC) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of GBX-1.15 Million (operating CF GBX-1.15 Million minus capex GBX1.00K) represents -1% of total liabilities (GBX1.65 Million). Check strategic asset allocation of Arecor Therapeutics PLC to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arecor Therapeutics PLC Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Arecor Therapeutics PLC across 9 annual periods. See Arecor Therapeutics PLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Arecor Therapeutics PLC (2018–2025)
Year-by-year free cash flow to debt coverage for Arecor Therapeutics PLC. For the full company profile including market capitalisation, see Arecor Therapeutics PLC (AREC) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.33x | GBX-2.19 Million | GBX-2.29 Million | GBX1.65 Million | ▲ +50.9% |
| 2024 | -2.71x | GBX-9.13 Million | GBX-9.15 Million | GBX3.37 Million | ▼ -178.4% |
| 2023 | -0.97x | GBX-5.69 Million | GBX-5.84 Million | GBX5.85 Million | ▲ +59.8% |
| 2022 | -2.42x | GBX-10.44 Million | GBX-10.78 Million | GBX4.31 Million | ▼ -6.7% |
| 2021 | -2.27x | GBX-5.38 Million | GBX-5.45 Million | GBX2.37 Million | ▼ -341.3% |
| 2020 | -0.51x | GBX-1.80 Million | GBX-1.86 Million | GBX3.51 Million | ▼ -32.3% |
| 2019 | -0.39x | GBX-426.50K | GBX-458.80K | GBX1.10 Million | ▲ +80.3% |
| 2019 | -1.97x | GBX-2.43 Million | GBX-2.50 Million | GBX1.23 Million | ▼ -473.2% |
| 2018 | -0.34x | GBX-479.65K | GBX-492.57K | GBX1.40 Million | — |